Published in Cancer Weekly, January 11th, 2011
"In this work, four traditional Portuguese apple cultivars (Bravo de Esmolfe, Malapio Fino, Malapio da Serra and Pero Pipo) and five exotic varieties (Golden, Starking, Fuji, Gala Galaxy and Reineta Parda) were evaluated in terms of their bioactivity using both cell-based and cell-free assays; 17 parameters were evaluated for each sample. obtained were submitted...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.